Paloma Partners’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Paloma Partners’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-15,000	Closed	-$187K	–	2433
2016 Q4	$187K	Buy	+15,000	New	+$181K	﹤0.01%	1849
2015 Q4	–	Sell	-57,563	Closed	-$336K	–	2060
2015 Q3	$336K	Buy	+57,563	New	+$443K	0.01%	1231
2013 Q4	–	Sell	-20,000	Closed	-$368K	–	1284
2013 Q3	$368K	Buy	+20,000	New	+$388K	0.01%	566

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Paloma Partners's ARIA Position: Q1 2017 in Review

Paloma Partners sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 15,000 shares — an estimated $187K sold.

Paloma Partners first reported a position in ARIA in Q3 2013 and held it in 3 quarters. The position peaked at $368K in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Paloma Partners reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Paloma Partners sold 15,000 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $187K.
Paloma Partners first reported a position in Ariad Pharmaceuticals Inc in Q3 2013 and held it in 3 quarters.
Paloma Partners's Ariad Pharmaceuticals Inc position peaked at $368K in Q3 2013.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Paloma Partners's 13F filing for Q1 2017, filed 15 May 2017.